Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Lord Mawson, and are more likely to reflect personal policy preferences.
Lord Mawson has not introduced any legislation before Parliament
Lord Mawson has not co-sponsored any Bills in the current parliamentary sitting
For security reasons, the Houses do not publish capital expenditure on security mitigating projects as providing this level of detail could enable an individual to infer the extent and nature of the works, and thus the vulnerabilities which they were intended to mitigate.
Staffing costs for Peers' Entrance cannot be disaggregated separately. However, they will not increase as a result of the installation of the new door at Peers Entrance.
The new entrance is fully accessible to wheelchair users and mobility impaired users. The installations meet requirements set out by the Building Regulations approved document M.
For security reasons we do not publicly disclose details of Parliament’s security arrangements.
The emergency exit and evacuation procedures have not been altered by the recent works at Peers’ Entrance.
Peers’ Entrance is not a designated evacuation route or assembly area, including for those with disabilities.
Proportionate and balanced regulation of charities is key to helping the sector deliver the vital work that it does. The Charities Act 2022, which gained Royal Assent in February 2022, implemented Law Commission recommendations to reform a number of processes in charity law. No formal impact assessment has yet been undertaken into the level of regulatory burden on charities, but in line with Government practice DCMS intends to conduct a post-Implementation review of the Charities Act 2022 by February 2027.
Proper safeguarding is a key governance priority for all charities and is core to the delivery of frontline services that charities provide. No formal impact assessment has been undertaken into the impacts of safeguarding regulation and guidance on charities.
The Charity Commission has published guidance for charities which helps charities understand their safeguarding responsibilities. The Government has also published an online safeguarding tool designed to help charities handle safeguarding allegations.
A post-implementation review will be conducted and published three to five years after Royal Assent, in line with usual Government practice. DCMS intends to conduct a post-Implementation review of the Charities Act 2022 by February 2027.
The Charities Act 2022, which gained Royal Assent in February 2022, implemented Law Commission recommendations to reform a number of processes in charity law. These include how charities can change their governing documents, sell land, make better use of permanent endowment funds, and merge with other charities.
The Act should reduce unnecessary or burdensome regulation that increases the sector’s costs and discourages people from volunteering to become trustees, whilst preserving important safeguards. The Law Commission’s recommendations are estimated to deliver savings for charities of £28m over a ten year period.
DCMS officials continue to review the charities’ legislative framework to ensure that regulation is balanced and proportionate.
Statistics on reported road injury collisions in Great Britain are published based on data reported by police via the data collection known as STATS19.
Within STATS19, reporting police officers can assign up to 6 factors which they believe may have contributed to the collision, including ‘poor or defective road surface’. Contributory factors are assigned based on the opinions of the reporting officer at the scene or within a short time of the collision, rather than a detailed investigation.
The number of collisions in each of the last 10 years with the factor ‘poor or defective road surface’ assigned is published in table RAS0701 on gov.uk and reproduced below:
Year | Reported road collisions in England with ‘poor or defective road surface’ assigned as a contributory factor |
2014 | 660 |
2015 | 544 |
2016 | 519 |
2017 | 465 |
2018 | 446 |
2019 | 437 |
2020 | 376 |
2021 | 429 |
2022 | 432 |
2023 | 532 |
The Department for Transport allocates capital funding to local highways authorities to enable them to maintain and improve their respective networks, based on their local knowledge, circumstances, and priorities. The funding is paid out as a grant under section 31 of the Local Government Act 2003, and is unringfenced. It is up to each authority to decide how best to spend it to fulfil its statutory duty under section 41 of the Highways Act 1980.
Revenue funding for highway maintenance is provided to local authorities each year by the Ministry of Housing, Communities and Local Government as part of the Local Government Finance Settlement. This funding is also unringfenced.
The Department publishes maintenance expenditure on local roads on gov.uk each year based on local authority outturn receipts. These show that capital expenditure on the local highway network is consistently higher than the funding provided by the Department for highway maintenance activities, which suggests that generally local authorities are not using the capital funding provided by the Department for other purposes.
The Department intends to introduce new reporting requirements on local highway authorities for the 2025/26 financial year, which will require them to provide further information to ensure residents can see how they intend to use the funding provided by the Government.
The Department’s officials meet regularly with local authority representatives and other experts in the road maintenance industry to discuss best practice. Ministers have also met with key stakeholder groups, including the Pothole Partnership which comprises organisations representing road users and industry.
The Department agrees that local highway authorities should focus on preventative rather than reactive maintenance activities, and this advice is set out in the Code of Practice on Well Managed Highway Infrastructure, which is available online. The Department is committed to updating this guidance and has begun work to scope out urgently which parts need updating and how. The Department strongly advocates a risk-based whole lifecycle asset management approach to local authority highways maintenance programmes, and encourages authorities to consider all parts of the highway network, such as bridges, cycleways, and lighting columns, and not just the fixing of potholes or resurfacing of roads.
Decisions on how much to spend on their local highway networks each year are matters for local highway authorities, who have a duty under Section 41 of the Highways Act 1980 to maintain the public highway network in their area. The Department for Transport collects and publishes on gov.uk each year data on authorities’ capital and revenue expenditure on their highway maintenance activities. The data shows that, at a national level, total spending on local road maintenance in the financial year 2022/23 was broadly similar to total spend in each of the previous five years.
This Government recognises the importance of well-maintained roads and has provided an additional £500m for highway maintenance for the year 2025/26 – a near 50% uplift on the current baseline. This has resulted in an 36% increase on average to individual local highway authority allocations, as well as providing highway maintenance funding top-ups to London authorities and mayoral areas already receiving City Region Sustainable Transport Settlements. These allocations can be found on gov.uk.
In addition, the Department is taking a number of steps to improve its understanding of the condition of local roads. It worked with the British Standards Institute and the highway sector to develop a new road condition data standard for local highway authorities, which was published last year. This will enable them to utilise new technologies, including AI, to identify potholes and other defects in their highway network more promptly.
The Department’s officials meet regularly with local authority representatives and other experts in the road maintenance industry to discuss best practice. Ministers have also met with key stakeholder groups, including the Pothole Partnership which comprises organisations representing road users and industry.
The Department agrees that local highway authorities should focus on preventative rather than reactive maintenance activities, and this advice is set out in the Code of Practice on Well Managed Highway Infrastructure, which is available online. The Department is committed to updating this guidance and has begun work to scope out urgently which parts need updating and how. The Department strongly advocates a risk-based whole lifecycle asset management approach to local authority highways maintenance programmes, and encourages authorities to consider all parts of the highway network, such as bridges, cycleways, and lighting columns, and not just the fixing of potholes or resurfacing of roads.
Decisions on how much to spend on their local highway networks each year are matters for local highway authorities, who have a duty under Section 41 of the Highways Act 1980 to maintain the public highway network in their area. The Department for Transport collects and publishes on gov.uk each year data on authorities’ capital and revenue expenditure on their highway maintenance activities. The data shows that, at a national level, total spending on local road maintenance in the financial year 2022/23 was broadly similar to total spend in each of the previous five years.
This Government recognises the importance of well-maintained roads and has provided an additional £500m for highway maintenance for the year 2025/26 – a near 50% uplift on the current baseline. This has resulted in an 36% increase on average to individual local highway authority allocations, as well as providing highway maintenance funding top-ups to London authorities and mayoral areas already receiving City Region Sustainable Transport Settlements. These allocations can be found on gov.uk.
In addition, the Department is taking a number of steps to improve its understanding of the condition of local roads. It worked with the British Standards Institute and the highway sector to develop a new road condition data standard for local highway authorities, which was published last year. This will enable them to utilise new technologies, including AI, to identify potholes and other defects in their highway network more promptly.
The Department’s officials meet regularly with local authority representatives and other experts in the road maintenance industry to discuss best practice. Ministers have also met with key stakeholder groups, including the Pothole Partnership which comprises organisations representing road users and industry.
The Department agrees that local highway authorities should focus on preventative rather than reactive maintenance activities, and this advice is set out in the Code of Practice on Well Managed Highway Infrastructure, which is available online. The Department is committed to updating this guidance and has begun work to scope out urgently which parts need updating and how. The Department strongly advocates a risk-based whole lifecycle asset management approach to local authority highways maintenance programmes, and encourages authorities to consider all parts of the highway network, such as bridges, cycleways, and lighting columns, and not just the fixing of potholes or resurfacing of roads.
Decisions on how much to spend on their local highway networks each year are matters for local highway authorities, who have a duty under Section 41 of the Highways Act 1980 to maintain the public highway network in their area. The Department for Transport collects and publishes on gov.uk each year data on authorities’ capital and revenue expenditure on their highway maintenance activities. The data shows that, at a national level, total spending on local road maintenance in the financial year 2022/23 was broadly similar to total spend in each of the previous five years.
This Government recognises the importance of well-maintained roads and has provided an additional £500m for highway maintenance for the year 2025/26 – a near 50% uplift on the current baseline. This has resulted in an 36% increase on average to individual local highway authority allocations, as well as providing highway maintenance funding top-ups to London authorities and mayoral areas already receiving City Region Sustainable Transport Settlements. These allocations can be found on gov.uk.
In addition, the Department is taking a number of steps to improve its understanding of the condition of local roads. It worked with the British Standards Institute and the highway sector to develop a new road condition data standard for local highway authorities, which was published last year. This will enable them to utilise new technologies, including AI, to identify potholes and other defects in their highway network more promptly.
The Government is considering its response to the 2022 consultation and will make an announcement in due course.
Prescription data is collected by the NHS Business Services Authority (NHSBSA) for the operational purpose of reimbursing and remunerating dispensing contractors for the costs of supplying drugs and devices, and providing essential and advanced services, to National Health Service patients.
The following table shows the total net ingredient cost (NIC) for prescription items with an oral route of administration, dispensed to patients aged 71 years old and over, for the financial years 2015/16 to 2023/24, and from April to November 2024/25:
Financial year | Tablet | Capsule | Liquid, solution, suspension, drops | Other formulations |
2015/16 | £1,128,000,000 | £336,000,000 | £155,000,000 | £35,000,000 |
2016/17 | £1,138,000,000 | £325,000,000 | £156,000,000 | £35,000,000 |
2017/18 | £1,211,000,000 | £273,000,000 | £146,000,000 | £34,000,000 |
2018/19 | £1,252,000,000 | £239,000,000 | £144,000,000 | £35,000,000 |
2019/20 | £1,423,000,000 | £254,000,000 | £148,000,000 | £38,000,000 |
2020/21 | £1,570,000,000 | £263,000,000 | £158,000,000 | £40,000,000 |
2021/22 | £1,581,000,000 | £250,000,000 | £164,000,000 | £45,000,000 |
2022/23 | £1,723,000,000 | £267,000,000 | £189,000,000 | £46,000,000 |
2023/24 | £1,742,000,000 | £279,000,000 | £218,000,000 | £49,000,000 |
2024/25 | £1,091,000,000 | £173,000,000 | £190,000,000 | £13,000,000 |
This answer is based on information extracted from the NHSBSA Data Warehouse, using all drug products where there was an indication of an oral route on the NHSBSA’s drug database.
The NHSBSA does not hold a single cost to the NHS. Total NIC is the amount that would be paid using the basic price of the prescribed medicine and the quantity prescribed, before any discounts, dispensing costs, or fees. It also does not include other costs to the NHS, such as those associated with purchasing or storing these medicines. The basic price is given either in the Drug Tariff or is determined from prices published by manufacturers, wholesalers, or suppliers. For branded medicines, the cost to the NHS will be partially offset by the statutory scheme and voluntary scheme.
The Medicines and Healthcare products Regulatory Agency continuously monitors the safety of medicines on the United Kingdom’s market and ensures the product information, which includes the patient information leaflet supplied with each pack of medicine, reflects what is known about the medicine, and provides information to support the safe use of the medicine. This includes information about the risks to particular groups of patients such as the elderly, details of possible side effects, and if action is needed to seek medical advice and information about the risk of interactions with other medicines, and the action that is needed to minimise the risks.
The Prescription Cost Analysis (PCA) provides the total number of prescription items of each medicine dispensed in the community in England. The following table shows the total number of items prescribed, based on information within the PCA and using British National Formulary Section 0403 for antidepressant drugs that have been dispensed in England regardless of where prescribed, as well as their net ingredient cost (NIC), for each calendar year from 2014 to 2023, and from January to November 2024:
Calendar year | Total number of items | Total NIC |
2014 | 57,149,109 | £265,008,698.97 |
2015 | 61,021,662 | £284,746,655.27 |
2016 | 64,703,639 | £266,562,024.17 |
2017 | 67,530,457 | £235,076,089.51 |
2018 | 70,873,979 | £202,526,719.66 |
2019 | 74,814,621 | £201,729,659.16 |
2020 | 78,866,866 | £352,682,885.77 |
2021 | 82,620,542 | £288,099,249.84 |
2022 | 85,404,864 | £224,648,497.13 |
2023 | 88,469,803 | £230,013,659.86 |
2024 | 84,251,563 | £207,585,360.44 |
Total | 815,707,105 | £2,758,679,499.78 |
The NHS Business Services Authority does not hold a single cost to the National Health Service. Total NIC is the amount that would be paid using the basic price of the prescribed medicine and the quantity prescribed, before any discounts, dispensing costs, or fees. It also does not include other costs to the NHS, such as those associated with purchasing or storing these medicines. The basic price is given either in the Drug Tariff or is determined from prices published by manufacturers, wholesalers, or suppliers.
Unintended consequences, such as potential side effects, associated with taking antidepressants are outlined in the Product Information provided with each pack of medicine. The safety of all medicines is kept under continuous review by the Medicines and Healthcare products Regulatory Agency, and the product information is updated as needed to reflect what is known about the medicine. The product information is designed to support but not replace the clinical conversation between the prescriber and patient on the benefits and risks of pharmacological treatment.
The Medicines Used in Mental Health statistical release includes information about prescribing in England for medicines classified within the British National Formulary section 0403, as antidepressant drugs. There were 6,873,381 total identified patients, aged 18 years old and over, in quarter two of 2024/25.
The Office of National Statistics (ONS) publishes population statistics for England on the ONS website. The estimated mid-year population for people aged 18 years old and over in England in 2023 was 45,691,677.
Based on the latest published data, the number of adults, those aged 18 years old and over, in England who received a prescription for antidepressant drugs in the quarterly period of July to September 2024 was 15% of the estimated 2023 mid-year population.
A number of anti-depressant products have been licenced by the Medicines and Healthcare products Regulatory Agency (MHRA). These medicines are prescription only, and must only be prescribed by a healthcare professional.
Each individual product is assessed for its efficacy and safety in a specific indication prior to the issuing of a marketing authorisation. Only when the benefit-risk analyses have been shown to be positive in relation to quality, safety, and efficacy, will a product obtain an approval.
The Product Information for each product will include not only the details of the indication, but will also include posology, or the dose recommendations, contra-indications, a list of known side-effects, and a reference to the Yellow Card Scheme, for reporting new side-effects. Safety is regularly monitored in order to detect any safety signal not recorded during the clinical trials and once the drug is available to a wider population.
Details of products approved by the MHRA, including therapeutic indications, can be found by searching ‘antidepressant’ on the MHRA website, which is available in an online only format.
The effectiveness of the product, which is measured post-authorisation, is considered by the National Institute for Health and Care Excellence (NICE), and other learned bodies, for the development of clinical guidance.
It should be noted that non-pharmacological alternatives may also be recommended to a patient, however this a decision for the healthcare professional.
The NICE is the independent body responsible for translating evidence into authoritative guidance and best practice for the health and care system. NICE guidelines provide recommendations in terms of both the effectiveness and cost-effectiveness of interventions and services, and National Health Service organisations are expected to take them fully into account in designing services that meet the needs of their local populations.
The NICE has published guidance on the treatment and management of depression in adults which provides recommendations on the use of antidepressants and non-drug treatments for depression.